TrademarkDir
EYEQ FORMULATION
LIVE

Serial Number

99020672

Owner

Orasis Pharmaceuticals Ltd.

Attorney

B. Brett Heavner

Filing Date

Jan 28, 2025

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EYEQ FORMULATION Trademark

Serial Number: 99020672

EYEQ FORMULATION is a trademark filed by Orasis Pharmaceuticals Ltd. on January 28, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Orasis Pharmaceuticals Ltd.

6 Maskit st., P.O.B 12929
Herzliya 4673328 , IL

Entity Type: 99

Trademark Details

Filing Date

January 28, 2025

Registration Date

Not Registered

Published for Opposition

August 19, 2025

Goods & Services

Pharmaceutical preparations for the treatment of eye disorders and diseases

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 14, 2026 EXRA
TEAS STATEMENT OF USE RECEIVED
Apr 14, 2026 EISU
SOU EXTENSION 1 GRANTED
Apr 14, 2026 EX1G
SOU EXTENSION 1 FILED
Apr 14, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 14, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 14, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 19, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 19, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 13, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 11, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 11, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 11, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 11, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 11, 2025 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 8, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 8, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 8, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 8, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 28, 2025 MAFR
NEW APPLICATION ENTERED
Jan 28, 2025 NWAP

Related Trademarks

More from this Owner

QLOSI

QLOSI

QLOSI

QLOSI

QLOSI

QLOSI

More in Same Class

NEWY

NEWY

ASAHI KASEI THERAPEUTICS

ASAHI KASEI THERAPEUTICS

PRIME460

PRIME460

CREATP

CREATP

INSTANT IRON FOR PIGLETS QUICK RESULTS SPECIAL PATENTED SHUNTING PROCESS IS COM PARABLE TO INJECTIONS WITHOUT THE RISK OF ABSCESS INFECTIONS. LABOR SAVING CAN BE GIVEN TO PIGLETS ON DAY ONE, WHILE CLIPPING MILK TEETH, DOCKING TAILS, ETC. NO NEED TO RECAPTURE. PLUS. INSTANT IRON PROVIDES ESSENTIAL NUTRIENTS THAT INJEC- TIONS DON'T PROVIDE: COPPER, ZINC, BIOTIN, FOLIC ACID AND B-COMPLEX. DIRECTIONS: ORAL ADMINISTRATION; HOLD PIGLET UPRIGHT, GIVE ONE PUMP (2 ML)IN MOUTH WAIT TEW SECONDS FOR PIGLET TO SWALLOW, THEN RELEASE PIGLET. ONE TREATMENT IS SUFFICIENT. SHAKE WELL. NO REFRIGERATION REQUIRED KEEP OUT OF DIRECT SUNLIGHT. KEEP CAP CLOSED TO

INSTANT IRON FOR PIGLETS QUICK RESULTS SPECIAL PATENTED SHUNTING PROCESS IS COM PARABLE TO INJECTIONS WITHOUT THE RISK OF ABSCESS INFECTIONS. LABOR SAVING CAN BE GIVEN TO PIGLETS ON DAY ONE, WHILE CLIPPING MILK TEETH, DOCKING TAILS, ETC. NO NEED TO RECAPTURE. PLUS. INSTANT IRON PROVIDES ESSENTIAL NUTRIENTS THAT INJEC- TIONS DON'T PROVIDE: COPPER, ZINC, BIOTIN, FOLIC ACID AND B-COMPLEX. DIRECTIONS: ORAL ADMINISTRATION; HOLD PIGLET UPRIGHT, GIVE ONE PUMP (2 ML)IN MOUTH WAIT TEW SECONDS FOR PIGLET TO SWALLOW, THEN RELEASE PIGLET. ONE TREATMENT IS SUFFICIENT. SHAKE WELL. NO REFRIGERATION REQUIRED KEEP OUT OF DIRECT SUNLIGHT. KEEP CAP CLOSED TO

TARGETED SUPPLEMENTS

TARGETED SUPPLEMENTS